Significant association seen for eGFR percentiles below the 25th percentile with risk for kidney failure with replacement ...
Data from eight participants continue to support safety and tolerability profile of tegoprubartMean eGFR increased over the measurement period, ...
Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.
Hoth Therapeutics has shared phase 2 results on its treatment of EGFR inhibitor-induced skin toxicities, ticking off another ...
Chinese pharma Hansoh Pharma (HKEX: 3692) has secured approval from China’s National Medical Products Administration for an expanded use of its EGFR inhibitor Ameile (almonertinib). The decision ...
ALX Oncology (NASDAQ:ALXO) outlined progress across its two clinical-stage programs—CD47 blocker evorpacept and EGFR-targeted ...
Reductions in measured GFR after bariatric surgery were positively correlated with baseline measured GFR before surgery, ...
In the evolving landscape of metastatic colorectal cancer, managing patients with RAS/BRAF wild-type tumors remains a ...
Deep-learning analysis of routine H&E slides accurately predicts key NSCLC driver mutations, supporting treatment in lung cancer care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback